Aragen Life Sciences IPO: Company files DRHP with SEBI for ₹800 crore fresh issue and OFS of up to 27.33 million equity shares.
Read Moredrug development
Emcure Takes Full Ownership of Gennova Biopharmaceuticals, Samit Mehta Named CEO
Gennova Biopharmaceuticals becomes a wholly owned Emcure subsidiary as Samit Mehta takes charge to drive biologics and biosimilars growth.
Read MoreSiddharth Mittal Appointed as Managing Director and CEO of Syngene International
Siddharth Mittal becomes Managing Director & CEO of Syngene International, succeeding Peter Bains and leading the company’s next phase of global growth.
Read MoreBiostate AI Secures Global Collaborations to Advance RNA-Based Precision Medicine
Biostate AI has filed over a dozen patents in RNA sequencing and AI, and has worked with more than 100 research groups in the U.S.
Read More



